2 active not recruiting, 1 withdrawn. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 2, Withdrawn 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Advanced Malignant Solid Neoplasm: new trials by email Literature Review of Advanced Malignant Solid Neoplasm trials Research Report on Advanced Malignant Solid Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer Olanzapine, Placebo Administration, Questionnaire Administration - Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm | Phase 3 | Withdrawn | Mayo Clinic | 2022-06-03 | 2024-05-06 | |
| Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients Olanzapine, Megestrol Acetate, Questionnaire Administration - Advanced Malignant Solid Neoplasm, Anorexia | Phase 3 | Active not recruiting | Alliance for Clinical Trials in Oncology | 227 | 2022-01-03 | 2026-07-30 |
| Open Labeled Placebo in Reducing Cancer Related Fatigue in Patients With Advanced Cancer Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration - Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm | Phase 2 / Phase 3 | Active not recruiting | M.D. Anderson Cancer Center | 100 | 2019-03-30 | 2026-08-11 |
Hematologic Neoplasms (2) · Anorexia (1) · Neoplasm Metastasis (1)
Neoplasms (3) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Neoplasms by Site (2) · Pathological Conditions, Signs and Symptoms (2) · Neoplastic Processes (1) · Pathologic Processes (1) · Signs and Symptoms (1) · Signs and Symptoms, Digestive (1)
Olanzapine (2) · Megestrol Acetate (1) · Waiting Lists (1)
Alliance for Clinical Trials in Oncology (1) · M.D. Anderson Cancer Center (1) · Mayo Clinic (1)
United States (2)
Aminah Jatoi, MD (1) · Charles L Loprinzi (1) · Sriram Yennu (1)
UG1CA189823 (1)